Could Hair Loss be a Relevant Symptom Associated with Chikungunya?
DOI:
https://doi.org/10.17140/TCOJ-2-106Keywords:
Chikungunya, Hair loss, Aedes mosquitoes, Aedes aegypti, Aedes albopictusAbstract
Chikungunya (CHIK) is a disease caused by a mosquito-borne alphavirus (the mosquitos Aedes aegypti or Aedes albopictus). The chikungunya virus (CHIKV) is present all over the world. Several clinical symptoms have been associated with CHIK including hair loss. The aim of this review is to present some symptoms related to CHIK, tissues and organs targeted by the CHIKV and to suggest how the infection can lead to hair loss. Searches were performed to verify the number of publications (NP) with the keywords “Chikungunya” and (i) “fever, or arthralgia, or rash, or myalgia, or fatigue, or depression, or insomnia, or pruritus, or patches, nausea, or vomiting, or headache, or erythema or hair loss” and (ii) some organs or tissues that are target to the arboviral alphaviruses associated with this disease. The total number of articles with the keyword “chikungunya” was 3176. Fever was the most cited symptoms and 50% of the publications were related to this symptom. Also, hair loss was found to be associated with CHIKV infection. Skin being the most cited organ, the total number of publications with “skin” under chikungunya summed up to only 2.77%. Although, fever is the most reported, arthralgia and rash have an important NP, and (ii) the main targets of CHIKV would be skin, kidneys and brain. A small NP is found with CHIK and hair loss. Hair loss may be idiopathic, and would be associated with a genetic predisposition, metabolic and hormonal abnormalities and aging. Also, as hair does not have a vital function in humans, it is possible to say that hair loss could not be considered in the clinical evaluation of the patient with CHIK. It is therefore possible to conclude that occurrence of hair loss is underestimated in CHIK.
References
Powers AM, Logue CH. Changing patterns of chikungunya virus: Re-emergence of a zoonotic arbovirus. J Gen Virol. 2007; 88: 2363-2377. doi: 10.1099/vir.0.82858-0
Coffey LL, Failloux AB, Weaver SC. Chikungunya virus-vec-tor interactions. Viruses. 2014; 24: 4628-4663.
Porterfield JH. Antigenic characteristics and classification of the Togaviridae. In: Schlesinger R, ed. The Togaviruses. New York, USA: Academic Press; 1980: 13-46.
Soumahoro MK, Gérardin P, Boëlle PY, et al. Impact of Chi-kungunya virus infection on health status and quality of life: A retrospective cohort study. PLoS One. 2009; 4: e7800. doi: 10.1371/journal.pone.0007800
Ramos-e-Silva M, Chaves Azevedo-e-Silva M, Carneiro SC. Hair, nail, and pigment changes in major systemic disease. Clin Dermatol. 2008; 26(3): 296-305. doi: 10.1016/j.clinderma-tol.2007.10.019
Ziegler SA, Lu L, da Rosa AP, Xiao SY, Tesh RB. An animal model for studying the pathogenesis of chikungunya virus in-fection. Am J Trop Med Hyg. 2008; 79(1): 133-139. Web site. http://www.ajtmh.org/content/79/1/133.long. Accessed January 16, 2017.
Turner GA, Bhogal RK. Hair and Aging. Skinmed. 2016; 14(5): 338-343.
Hunt N, McHale S. The psychological impact of alopecia. BMJ. 2005; 331: 951-953. Web site. http://search.proquest. com/openview/b92307a5dc9d8cdb21b0bfe85268beab/1?pq-origsite=gscholar&cbl=2040978. Accessed January 16, 2017.
Watras MM, Patel JP, Arya R. Traditional anticoagulants and hair loss: A role for direct oral anticoagulants? A review of the literature. Drugs Real World Outcomes. 2016; 3(1): 1-6. doi:
1007/s40801-015-0056-z 10. Gallegos KM, Drusano GL, D Argenio DZ, Brown AN. Chikungunya Virus: In Vitro Response to Combination Thera-py With Ribavirin and Interferon Alfa 2a. J Infect Dis. 2016; 214(8): 1192-1197. doi: 10.1093/infdis/jiw358
Abdelnabi R, Neyts J, Delang L. Antiviral Strategies Against Chikungunya Virus. Methods Mol Biol. 2016; 1426: 243-253. doi: 10.1007/978-1-4939-3618-2_22
Sourisseau M, Schilte C, Casartelli N, et al. Characterization of reemerging chikungunya virus. PLoS Pathog. 2007; 3: e89. doi: 10.1371/journal.ppat.0030089
Krejbich-Trotot P, Denizot M, Hoarau JJ, Jaffar-Bandjee MC, Das T, Gasque P. Chikungunya virus mobilizes the apop-totic machinery to invade host cell defenses. FASEB J. 2011; 25(1): 314-325. doi: 10.1096/fj.10-164178
Ozden S, Huerre M, Riviere JP, et al. Human muscle satel-lite cells as targets of Chikungunya virus infection. PLoS ONE. 2007; 2: e527. doi: 10.1371/journal.pone.0000527
Cunha BA, Leonichev VB, Raza M. Chikungunya fever pre-senting with protracted severe pruritus. IDCases. 2016; 6: 29- 30. doi: 10.1016/j.idcr.2016.09.003
Borgherini G, Poubeau P, Jossaume A, et al. Persistent ar-thralgia associated with chikungunya virus: A study of 88 adult patients on reunion island. Clin Infect Dis. 2008; 47: 469-475. doi: 10.1086/590003
Borgherini G, Poubeau P, Staikowsky F, et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007; 44(11): 1401-1407. doi: 10.1086/517537
Bandyopadhyay D, Ghosh SK. Mucocutaneous features of Chikungunya fever: A study from an outbreak in West Bengal, India. Int J Dermatol. 2008; 47(11): 1148-1152. doi: 10.1111/j.1365-4632.2008.03817.x
Kantor AM, Dong S, Held NL, et al. Identification and initial characterization of matrix metalloproteinases in the yellow fever mosquito, Aedes aegypti. Insect Mol Biol. 2017; 26(1): 113-126. doi: 10.1111/imb.12275
Lokireddy S, Vemula S, Vadde R. Connective tissue me-tabolism in chikungunya patients. Virol J. 2008; 5: 31, doi: 10.1186/1743-422X-5-31
Rodríguez-Morales AJ, Cardona-Ospina JA, Fernanda Urbano-Garzón S, Sebastian Hurtado-Zapata J. Prevalence of Post-Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken). 2016; 68: 1849-1858. doi: 10.1002/acr.22900
Furuya-Kanamori L, Liang S, Milinovich G, et al. Co-dis-tribution and co-infection of chikungunya and dengue viruses. BMC Infect Dis. 2016; 16: 84. doi: 10.1186/s12879-016-1417-2
Thiberville SD, Moyen N, Dupuis-Maguiraga L, et al. Chi-kungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 2013; 99(3): 345-370. doi: 10.1016/j. antiviral.2013.06.009
Mirmirani P. Managing hair loss in midlife women. Maturi-tas. 2013; 74(2): 119-122. doi: 10.1016/j.maturitas.2012.10.020
Yang SY, Lee HW, Lee YJ, Park SJ, Yoo KY, Kim HJ. Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea. Clin Mol Hepa-tol. 2015; 21(2): 125-130. doi: 10.3350/cmh.2015.21.2.125
Vanlandingham DL, Hong C, Klingler K, et al. Differential infectivities of o’nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes. Am J Trop Med Hyg. 2005; 72(5): 616-621. Web site. http://www.ajtmh. org/content/72/5/616.long. Accessed January 16, 2017.
Walker GM, Woodall JP, Haddow AJ, Williams MC. O’nyong-nyong fever: An epidemic virus disease in East Africa. VI. Alopecia in mice experimentally infected with o’nyong-nyong virus. Trans R Soc Trop Med Hyg. 1962; 56(6): 496-503. doi: 10.1016/0035-9203(62)90073-1
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Trichology and Cosmetology (TC) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.